Automated Cryogenic Storage Systems Market Global Report 2026

The automated cryogenic storage systems market size has grown rapidly in recent years. It will grow from $2.64 billion in 2025 to $2.92 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing biobanking activities, rising pharmaceutical research, growing demand for long-term biological sample preservation, expanding clinical research programs, and increasing adoption of laboratory automation.

The automated cryogenic storage systems market size is expected to see rapid growth in the next few years. It will grow to $4.31 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing cell and gene therapy development, rising demand for precision medicine research, growing investment in biorepositories, expanding regenerative medicine applications, and increasing demand for secure automated sample storage. Major trends in the forecast period include increasing adoption of high-density sample storage, rising demand for automated biobank management, expanding ultra-low-temperature sample preservation, growing integration of touch-free sample handling, and increasing focus on sample integrity and traceability.

The growing demand for personalized medicine is expected to drive the growth of the automated cryogenic storage systems market in the coming years. Personalized medicine refers to a medical approach that tailors disease prevention, diagnosis, and treatment according to an individual's genetic, molecular, and clinical characteristics. The demand for personalized medicine is increasing due to advances in genomics, biomarker research, and targeted therapies that require precise analysis and long-term preservation of patient-specific biological samples. Automated cryogenic storage systems support personalized medicine by providing secure, automated, ultra-low-temperature storage of biological specimens while maintaining sample integrity, traceability, and efficient retrieval for clinical and research applications. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, a significant increase from six approvals in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the automated cryogenic storage systems market.

Major companies operating in the automated cryogenic storage systems market are focusing on developing advanced solutions, such as liquid nitrogen (LN₂)-based robotic storage platforms, to enhance sample integrity, support regulatory compliance, and meet the increasing demand for secure biological sample management in clinical and laboratory environments. Liquid nitrogen (LN₂)-based robotic storage platforms are automated cryogenic storage systems that use liquid nitrogen to preserve biological samples at ultra-low temperatures while enabling robotic sample storage, retrieval, and inventory management with minimal manual intervention. For instance, in February 2023, Azenta Inc., a US-based life sciences company, launched the Cryo Store Pico, an automated cryogenic storage system designed for clinical and laboratory applications. The system provides automated LN₂-based cryogenic storage for high-value biological samples while offering controlled sample access, end-to-end traceability, regulatory compliance support, a compact footprint, and ease of operation. It is designed to support cell and gene therapy (CGT) developers, manufacturers, hospitals, and clinical laboratories by bringing automated cryogenic sample management closer to the point of use.

In October 2024, TMRW Life Sciences, a US-based fertility technology company, partnered with Cryoport Systems to enhance standards for the offsite storage and biologistics of frozen eggs, embryos, and sperm. The partnership aims to integrate automated cryogenic specimen management with cryogenic biologistics and storage services to improve specimen safety, traceability, and operational efficiency for fertility clinics and reproductive medicine providers. Cryoport Systems is a US-based provider of temperature-controlled supply chain solutions specializing in cryogenic logistics, storage, and biologistics for the life sciences industry.

Major companies operating in the automated cryogenic storage systems market are Thermo Fisher Scientific Inc., Azenta Inc., Cryoport Systems Inc., Hamilton Company, BioLife Solutions Inc., Qingdao Haier Biomedical Co. Ltd., LiCONiC AG, Cryotherm GmbH & Co. KG, Askion GmbH.

North America was the largest region in the automated cryogenic storage systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cryogenic storage systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the automated cryogenic storage systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.